Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

NWBO-5M-Note

More Like This

PR Newswire associated0

Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities

PR Newswire associated0

Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application

PR Newswire associated0

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property

PR Newswire associated0

Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification

PR Newswire associated0

Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma

Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.

Business Wire logo

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development